KERRA, Mixed Medicinal Plant Extracts, Inhibits SARS-CoV-2 Targets Enzymes and Feline Coronavirus
Authors:
- Supaphorn SeetahaSSSupaphorn Seetaha
- Phatcharin KhamplongPKPhatcharin Khamplong
- Panatda WanaragthaiPWPanatda Wanaragthai
- Thitinan AiebchunTAThitinan Aiebchun
- Siriluk RatanabunyongSRSiriluk Ratanabunyong
- Sucheewin KrobthongSKSucheewin Krobthong
- Yodying YingchutrakulYYYodying Yingchutrakul
- Jatuporn RattanasrisompornJatuporn Rattanasrisomporn
- Kiattawee ChoowongkomonKCKiattawee Choowongkomon
Open Access
Abstract
The COVID-19 pandemic affects all parameters, especially healthcare professionals, drugs and medical supplies. The KERRA is a mixed medicinal plant capsule that is used for the treatment of patients with high fever, with food and drug administration approved by FDA Thailand. Recently, KERRA showed induced quicker recovery for COVID-19 patients. Therefore, it is possible that some ingredients in KERRA could inhibit SARS-CoV-2. In this study, two important replication-related enzymes in SARS-CoV-2, a main protease and an RNA-dependent RNA polymerase (RdRp), were used to study the effect of KERRA. The results showed that KERRA inhibited the SARS-CoV-2 main protease and SARS-CoV-2 RdRp with IC50 values of 49.91 ± 1.75 ng/mL and 36.23 ± 5.23 µg/mL, respectively. KERRA displayed no cytotoxic activity on macrophage cells at concentrations lower than 1 mg/mL and exhibited anti-inflammatory activity. Additionally, KERRA was used against a feline coronavirus (feline infectious peritonitis (FIP)) infection with an EC50 value of 134.3 μg/mL. This study supports the potential use of KERRA as a candidate drug for COVID-19.Keywords
All Related Versions
Funding Information
- Kasetsart University (FF (KU) 25.64)
This publication has 49 references indexed in Scilit:
- Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and PterostilbeneAntimicrobial Agents and Chemotherapy, 2017
- Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid‐independent mechanismBritish Journal of Pharmacology, 2017
- Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosisBioorganic & Medicinal Chemistry Letters, 2012
- Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytesIn Vitro Cellular & Developmental Biology - Animal, 2011
- Tarennane and Tarennone, Two Novel Chalcone Constituents from Tarenna attenuataPlanta Medica, 2007
- Immunomodulatory activity of a chymotrypsin inhibitor from Momordica cochinchinensis seedsJournal of Peptide Science, 2006
- Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stressesJournal of Experimental Biology, 2005
- Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique1Acta Pharmacologica Sinica, 2005
- Hepatoprotective Effect of Combretum quadrangulare and Its Constituents.Biological and Pharmaceutical Bulletin, 2000
- New intramolecularly quenched fluorogenic peptide substrates for the study of the kinetic specificity of papainFEBS Letters, 1992